1 / 25

Health Care Reform: Planning to Move Ahead

Health Care Reform: Planning to Move Ahead. Presentation to: CADPAAC Mady Chalk, Ph.D. Treatment Research Institute May, 2010. Areas of Focus. Integration Role of Technology in Delivery Treatment Interventions Reimbursement and Revenues. Medical Accountability Consumer/Family Role

keren
Download Presentation

Health Care Reform: Planning to Move Ahead

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Health Care Reform: Planning to Move Ahead Presentation to: CADPAAC Mady Chalk, Ph.D. Treatment Research Institute May, 2010

  2. Areas of Focus • Integration • Role of Technology in Delivery • Treatment Interventions • Reimbursement and Revenues • Medical Accountability • Consumer/Family Role • Performance Expectations • Role in Health Care • Access • Value/Cost

  3. Medical Accountability • Environment: • Major focus on medical home in primary care setting • Pressure to implement EHRs • Field still struggling with hand-offs and transitions between levels of care/agencies • Co-morbidity (MH/SA and MED/SA) issues are still befuddling payers and providers

  4. Medical Accountability • Questions: • As a payer—what are the most important aspects of accountability? • Have you identified some clear expectations that promote accountability? How have or can you make your providers more accountable? • What activities are you promoting in treatment of co-morbid conditions? Have they worked? How do you know?

  5. Patient/Family Role • Environment: • Focus on patient centered care – adaptation of treatment services • Increase pressure on offering choice of provider • New eligibles—different age/socio-economic group—maybe more vocal about their treatment and treatment options • Continued expansion of opportunities for consumers to purchase care via vouchers

  6. Patient/Family Role • Questions • Have you articulated a role for patients and families? What is it? • How do you ensure that providers reinforce your message? • What is the patient or family’s role in accounting for their care? • How do patient/families participate in your QI process? What have you learned from them?

  7. Performance Expectations • Environment • Implementing NQF Standards of Care • Decreasing drop-outs/increasing engagement, retention, and continuing care • Increasing use of medications as part of comprehensive treatment • Continuous monitoring during treatment and use of data to adapt treatment services during treatment

  8. Performance Expectations • Questions • Have you disseminated the NQF Standards of Care to your stakeholders? • How are you introducing performance expectations into contracts and funding for treatment? • How are you monitoring performance of treatment providers?

  9. Role in Health Care • Environment: • Increase access to treatment through FQHCs • SBIRT is both an NQF Standard and consider important to provide in healthcare settings • Medicaid authorities may (or may not) include SSA in the decision-making process about changes in benefits, providers, services and reimbursement • Pressures by health plans to have credentialed practitioners deliver services • Linking health and specialty care is considered critical

  10. Role in Health Care • Questions: • Have you been involved in health care discussions (statewide or locally)? • If so, what has been your role? • How have or will you responded to financial pressures by other payers? • What is your role in supporting your current providers to be ready for competition from healthcare programs? • What are you doing to link health care and specialty treatment providers?

  11. Access • Environment: • Access is still a premium to payers • Still defined in fairly traditional terms • Payers/DOI/MCEs will be tracking access for newly eligible patients more closely • Assumes new coverage = new or different utilization patterns and services

  12. Access • Questions: • Have you defined “access” for the services you purchase? If so, how is it defined? • How do you track access? • What do you do when there are access problems? • How do you think new sources of financing will affect access to care?

  13. Value/Cost • Environment: • Identification of services/practices that add value • Proof or evidence to support purchasing decisions • Payers more likely to define value in terms of savings or offsets—not necessarily on improved health outcomes • Will have to show value to the customer who will have some “skin” in the game (deductibles, co-pays) • State payers are developing “purchasing plans”

  14. Value/Cost • Questions: • How have you defined value—what are your measures? • Do you base your purchasing decisions on the value derived from the service or other factors? • What are these other factors? • What evidence do you use when developing or changing your purchasing plan?

  15. Integration • Environment: • Developing standards for integrated care • Providers are further along than payers • Still an assumption that carve-ins will get you closer to integration • Reimbursement rules don’t necessarily encourage integration at the practice level • Still focusing on differences versus similarities • Public payer silos continue to thwart integration

  16. Integration • Question: • Can you articulate your vision/model for integrated care? • Who shares or understands this vision? • What will it take to implement you vision? • What are some implementation barriers? • What are three current models in your jurisdiction that are truly integrated?

  17. Workforce • Environment: • Payers equate a credentialed workforce with quality although a significant portion of workforce is not credentialed • All over the map regarding a definition of competency (versus credentialed) • Good supervision is diverted by productivity expectations and reimbursement • Recovery support providers have momentum and creating formal networks to compete for dollars

  18. Workforce • Questions: • What is your workforce development plan? • Does it apply to specialty or primary care settings? • What resources have you dedicated to workforce development? • Who have you identified and enlisted as partners in developing a competent workforce?

  19. Role of Technology in Delivery • Environment: • Technology is moving faster than practice • There are simple uses of technology to enhance access (texting reminders) • The “payer jury” is still out on the use of simple technology solutions (e.g. telephone counseling) • Investment in technology in the provider community is spotty

  20. Role of Technology in Delivery • Questions: • Have you identified a clear role for technology when purchasing services? • Are your providers using technology for delivering services? Has it produced value? • Do your payer partners understand the use of technology in delivering SUD services?

  21. Treatment Interventions • Environment: • Interventions should produce value and we have evidence of what works • Pressures to keep buying the “same old” • Other payers don’t fully embrace newer interventions • We aren’t good at doing the elevator speech in describing interventions (process versus result)

  22. Treatment Interventions • Questions: • What is the role of purchasers in promoting current treatment interventions with: • Clients • Providers • Other payers • How do purvhasers identify, spread and sustain preferred treatment interventions?

  23. Reimbursement • Environment: • Continued focus by payers on purchasing units of services • Some initial discussion re: purchasing episodes of care versus widgets • Pay for performance strategies not widely used yet • Different payers/different rates/same services

  24. Reimbursement • Questions: • Are you getting what you pay for? • What changes would you like to make in your reimbursement methodology? Why? • What barriers will you encounter if you make these changes? • How will these changes impact other public payers?

  25. For more information contact: Mady Chalk, Ph.D. Treatment Research Institute mchalk@tresearch.org

More Related